Search For "drug"
Coronavirus: Too early to discuss pricing of remdesivir, says US' Departme
Updated : 6 years, 2 months ago IST
Washington DC [USA], May 28 (ANI): The Department of Health and Human Services has said that it is too early to discuss the pricing of 'remdesivir', the drug which has raised everyone's hopes of treating the coronavirus.
Read More
Alex Hales "might take some more time" to return: Eoin Morgan
Updated : 6 years, 2 months ago IST
London [UK], May 28 (ANI): England ODI skipper Eoin Morgan said that opening batsman Alex Hales would "might take some time" to return to the team after he was axed from England's World Cup squad last summer for failing a second test for recreational drug use.
Read More
France officially bans hydroxychloroquine as treatment against COVID-19
Updated : 6 years, 2 months ago IST
Paris [France], May 28 (Sputnik/ANI): France on Wednesday (local time) officially banned hydroxychloroquine as a treatment for COVID-19 after a series of medical studies revealed that the malaria drug could be harmful.
Read More
Lancet study is not randomised clinical trial, only analysis of hospital r
Updated : 6 years, 2 months ago IST
New Delhi [India], May 27 (ANI): Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per simmering reports cited by the World Health Organisation (WHO), Shekher Mande, Director General of the Council of Scientific and Industrial Research (CSIR), India, said on Wednesday t
Read More
Researchers find no benefit for treatment used to avoid surgery for abdomi
Updated : 6 years, 2 months ago IST
Washington D.C. [USA], May 27 (ANI): Patients with a vascular condition, called the abdominal aortic aneurysm, received no benefits from taking a common antibiotic drug to reduce inflammation, finds a new landmark study.
Read More
Decided not to deny health workers HCQ based on risk-benefit analysis: ICM
Updated : 6 years, 2 months ago IST
New Delhi [India], May 26 (ANI): Noting that a lot of drugs are being repurposed for treatment of COVID-19, ICMR Director-General Dr Balram Bhargava on Tuesday said that prophylactic use of Hydroxychloroquine (HCQ) for health care workers had been recommended on the basis of risk-benefit a
Read More
Hydroxychloroquine poses little risk when administered alone in mild cases
Updated : 6 years, 2 months ago IST
New Delhi [India], May 26 (ANI): Dr Randeep Guleria, Director, All India Institute of Medical Sciences (AIIMS), New Delhi, on Tuesday said that 'judicious, and appropriate' use of hydroxychloroquine (HCQ) as a standalone drug should not pose any health risks in COVID-19 cases.
Read More
Sri Lanka Cricket suspends Shehan Madushanka for 'alleged possession of il
Updated : 6 years, 2 months ago IST
Colombo [Sri Lanka], May 26 (ANI): The Sri Lanka Cricket (SLC) on Tuesday suspended Shehan Madushanka from all forms of cricket with immediate effect after he was arrested for alleged possession of illegal drugs.
Read More
Glenmark to start new phase 3 clinical trial for hospitalised patients of
Updated : 6 years, 2 months ago IST
Mumbai (Maharashtra) [India], May 26 (ANI): Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential Covid-19 treatment strategy.
Read More
WHO temporarily suspends trial of hydroxychloroquine
Updated : 6 years, 2 months ago IST
Geneva [Switzerland], May 26 (ANI): The World Health Organisation (WHO) on Monday (local time) temporarily suspended the clinical trial of malarial drug hydroxychloroquine for the treatment of coronavirus.
Read More
Samsung gets approval from South Korea to use ECG feature on Galaxy Watch
Updated : 6 years, 2 months ago IST
New York [US], May 25 (ANI): South Korea's Ministry of Food and Drug Safety has granted approval to Samsung to use the Electrocardiogram (ECG) feature for measuring heart rhythms on the Galaxy Watch Active 2.
Read More
Study unveils novel strategy for diabetes treatment
Updated : 6 years, 2 months ago IST
Washington D.C. [USA], May 24 (ANI): Combining a once-popular but largely abandoned treatment for Type 2 diabetes with another drug could be used again to eliminate problematic side effects, say the findings of a novel study.
Read More